
Maria, the eldest daughter of Russian President Vladimir Putin, has publicly discussed anti-aging research, and the Russian government has listed 2028 to 2030 as the target timetable for related drugs.
AI-generated summary
Russian officials are promoting a national health technology plan, covering research on regenerative medicine and aging mechanisms.
Maria Vorontsova, the eldest daughter of Russian President Vladimir Putin and an endocrinologist, openly talks about anti-aging research.
Maria Vorontsova, the eldest daughter of Russian President Vladimir Putin and an endocrinologist, recently talked about anti-aging research and expected that medicine may make progress in anti-aging in the next 10 to 20 years. The Russian government has listed 2028 to 2030 as the target timetable for related drugs, and Putin himself has talked with Chinese President Xi Jinping in the past about the possibility of extending life and immortality.
This conversation was reported on the 20th by The Moscow Times, an independent news media based in Amsterdam that reports on Russian issues in English and Russian. Maria spoke at an event at the Moscow School of Management Skolkovo about research directions to extend human lifespan and the limitations currently faced by the scientific community.
Russian Deputy Prime Minister Tatyana Golikova said in 2025 that researchers plan to obtain and start using drugs that can restore aging cells to a younger state between 2028 and 2030. This is an official research and development goal, and it does not mean that the relevant drugs have been developed or have been proven to be effective in delaying human aging.
Maria's life extension research was divided into two phases. The first stage is to help people live to the natural life span of about 85 to 90 years old through healthy living habits, proper diet and regular health check-ups; the second stage is to try to break through the natural life span limit. She described the latter as akin to trying to "cheat God or nature," but admitted that the scientific community's progress in breaking through the natural lifespan is still limited.
Unlisted diseases of aging become a hurdle for the development of anti-aging drugs
One difficulty in developing anti-aging drugs is that aging has not yet been officially classified as a disease. Maria pointed out that drug development usually requires clear diagnostic standards and clinical trials, and the positioning of aging in medicine has therefore become an issue that related research must face.
Relevant research in Russia is included in the national health technology plan promoted by the government, covering research on regenerative medicine, preventive medicine, aging mechanisms and age-related diseases. Officials hope to extend people's healthy lifespan through these projects, but currently public information is not enough to confirm that Russia has developed drugs that can effectively delay human aging.
Putin has also shown interest in extending lifespan. According to the Wall Street Journal, in September 2025, before Putin, Xi Jinping and North Korean leader Kim Jong-un attended a military parade in Beijing, Putin talked about organ transplantation and life extension through a translator. Xi Jinping mentioned that humans may live to be 150 years old by the end of this century, and Kim Jong-un smiled on the side. This conversation, accidentally recorded without turning off the microphone, exposed the discussion between the three people on life extension and immortality.
On September 3, 2025, Putin (left), Xi Jinping (middle) and Kim Jong-un (right) attended a military parade in Beijing. According to reports, Putin earlier talked about organ transplantation and extending life span, and Xi Jinping also mentioned that humans may live to be 150 years old in the future.

The death of stock market commentator Louie Shum Chun-ying has prompted public health awareness regarding heart disease in Hong Kong, where over 6,500 deaths were recorded in 2024. Experts emphasize the importance of bystander intervention during medical emergencies.

Jinzhu Jiayuan in Wenzhou, Zhejiang has "embedded" vocational colleges into the elderly care park. Through the five-in-one "medical, health care and education" model, nursing students can receive practical training in real scenarios, while meeting the medical and care needs of the elderly and easing the manpower gap in elderly care services.

A pivotal trial of Ebola vaccines has begun in the Democratic Republic of Congo, where the epidemic originated. The first participant was vaccinated in Bunia using Merck & Co.’s Ervebo shot.

A study presented at the American Heart Association Annual Meeting showed that adults with insomnia who had prescribed melatonin for at least 1 year had a higher rate of heart failure diagnoses within 5 years. The study has not yet been peer-reviewed, and experts stress it cannot directly prove cause and effect.

The Kenyan Ministry of Health confirmed the second death from Ebola in the country. The deceased was a close relative of the first person who died. The total number of confirmed cases in Kenya now reaches 9, and the authorities have quarantined 135 contacts.

The Taipei Public Health Practitioners Association and the National Health Service held a forum at Chengdu University to advocate the legislation of the "Public Health Service Act" to clarify government responsibilities, improve the professional positioning and manpower allocation of public health practitioners, and respond to the new public health challenges brought about by a super-aging society and chronic diseases.